Skip to Main Content

Paper Details

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> Amplification.
J Clin Oncol
14
2023
Author NameAffiliation
Thomas J GeorgeUniversity of Florida Health Cancer Center
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2